NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 45 filers reported holding NEOS THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $191,000 | +57.9% | 73,255 | 0.0% | 0.00% | – |
| Q4 2018 | $121,000 | -41.3% | 73,255 | +72.9% | 0.00% | – |
| Q3 2018 | $206,000 | -22.3% | 42,374 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $265,000 | -16.4% | 42,374 | +10.8% | 0.00% | 0.0% |
| Q1 2018 | $317,000 | -20.4% | 38,250 | -1.9% | 0.00% | 0.0% |
| Q4 2017 | $398,000 | +11.8% | 39,010 | +0.2% | 0.00% | 0.0% |
| Q3 2017 | $356,000 | +43.0% | 38,915 | +14.1% | 0.00% | 0.0% |
| Q2 2017 | $249,000 | -5.7% | 34,115 | -6.8% | 0.00% | 0.0% |
| Q1 2017 | $264,000 | +59.0% | 36,615 | +29.3% | 0.00% | – |
| Q4 2016 | $166,000 | -13.5% | 28,315 | -2.7% | 0.00% | – |
| Q3 2016 | $192,000 | -28.1% | 29,115 | +1.0% | 0.00% | -100.0% |
| Q2 2016 | $267,000 | +107.0% | 28,815 | +140.1% | 0.00% | – |
| Q1 2016 | $129,000 | -11.6% | 12,000 | +17.6% | 0.00% | – |
| Q4 2015 | $146,000 | -31.1% | 10,200 | +1.0% | 0.00% | -100.0% |
| Q3 2015 | $212,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,971,014 | $6,413,000 | 4.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 3,711,454 | $4,788,000 | 0.66% |
| Proxima Capital Management, LLC | 206,000 | $266,000 | 0.36% |
| Nantahala Capital Management | 4,610,000 | $5,947,000 | 0.18% |
| Alambic Investment Management, L.P. | 219,090 | $283,000 | 0.18% |
| Wealthstar Advisors, LLC | 73,295 | $95,000 | 0.06% |
| ALGERT GLOBAL LLC | 77,845 | $100,000 | 0.04% |
| Western Standard LLC | 25,935 | $33,000 | 0.02% |
| Allred Capital Management, LLC | 24,995 | $33,000 | 0.02% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 320,993 | $414,000 | 0.02% |